NEWS AND ANNOUNCEMENTS

PEDIATRICS ◽  
1972 ◽  
Vol 49 (1) ◽  
pp. 155-159

Symposium on Reading Disabilities in Children: The Eye Section of the California Medical Association will sponsor an interdisciplinary symposium on "Reading Disabilities in Children," at the San Francisco Hilton Hotel, on Sunday, February 13, 1972. Dr. Arthur Keeney of Philadelphia is the invited guest speaker. The panel will comprise representatives of ophthalmology, pediatrics, child psychiatry, and education. For information contact Rush M. Blodget, Jr., M.D., Redding Ophthalmology Group, 1950 Court Street, Redding, California 96001. Obstetrics-Pediatrics Symposium : The Department of Obstetrics and Gynecology of Good Samaritan Hospital, in cooperation with the same Department of Saint Joseph's Hospital and Medical Center, both of Phoenix, will present a symposium, "Newer Concepts in Delivery of Obstetrical and Perinatal Care," February 25-26, 1972.

1986 ◽  
Vol 43 (2) ◽  
pp. 396-401
Author(s):  
Paulette K. Egging ◽  
Marilyn L. Slotfeldt

1978 ◽  
Vol 24 (10) ◽  
pp. 1845-1845

Abstract Volume 24 p 366, Fig. 3: The serum concentration data plotted in Figure 3 are five times too high. The sentence starting the second paragraph on page 366 should read: "Intravenous administration of 1 g of cefuroxine to the human volunteer yielded a concentration of 86.6 mg/liter 15 mm after injection." p 481: The third sentence in the Results and Discussion section should read "... revealed LD-1 isoenzyme in fraction 3, predominant amounts of LD-2 isoenzyme in fraction 2, and LD isoenzymes 3, 4, and 5 in fraction 1." p 520: The authors (p 522) of the Letter on hyperphosphatemia should also include M. E. De Broe (Dept. of Nephrology, Clinical Chemistry, University Hospital Gent, B-9000 Gent, Belgium), P. De Cock, and J. Jacken (Dept. of Pediatrics, University Hospital Leuven, B-3000 Leuven, Belgium). p 730, column three: "4000 nmol/liter" and "20 nmol/liter" should read "4000 µmol/liter" and "20 µmol/liter." p. 806: Units in Tables 1 and 2 should be "µg/10 ml." In column two, second full paragraph, change the wording to read" ... regard 250 ng as the lower practical limit." p 1083: Fig. 1, sublegend: change the dimension of the retainer from 57 mm to 28.5 mm. The scale shown in the Figure should read 0-2.5 cm instead of 0-5 cm. p 1086, center column, third paragraph: for "222" read "0.222." p 1129: Footnote superscripts in the headings of Table 3 should be corrected to: (Column A) "Day-to-daya precision:SD from meand of duplicate differences" (Column B) "Overall long. termb precision: Mean SDe" (Column C) "Overallc bias" p 1304: Add the acknowledgment: "This work was supported in part by Biomedical Research Support Grant No. S07-RR-05593-10 to Good Samaritan Hospital Medical Center." p 1467: Change "4 to 6000" to read "4 to 5000."


2013 ◽  
Vol 93 (7) ◽  
pp. 975-985 ◽  
Author(s):  
Heidi J. Engel ◽  
Shintaro Tatebe ◽  
Philip B. Alonzo ◽  
Rebecca L. Mustille ◽  
Monica J. Rivera

Background Long-term weakness and disability are common after an intensive care unit (ICU) stay. Usual care in the ICU prevents most patients from receiving preventative early mobilization. Objective The study objective was to describe a quality improvement project established by a physical therapist at the University of California San Francisco Medical Center from 2009 to 2011. The goal of the program was to reduce patients' ICU length of stay by increasing the number of patients in the ICU receiving physical therapy and decreasing the time from ICU admission to physical therapy initiation. Design This study was a 9-month retrospective analysis of a quality improvement project. Methods An interprofessional ICU Early Mobilization Group established and promoted guidelines for mobilizing patients in the ICU. A physical therapist was dedicated to a 16-bed medical-surgical ICU to provide physical therapy to selected patients within 48 hours of ICU admission. Patients receiving early physical therapy intervention in the ICU in 2010 were compared with patients receiving physical therapy under usual care practice in the same ICU in 2009. Results From 2009 to 2010, the number of patients receiving physical therapy in the ICU increased from 179 to 294. The median times (interquartile ranges) from ICU admission to physical therapy evaluation were 3 days (9 days) in 2009 and 1 day (2 days) in 2010. The ICU length of stay decreased by 2 days, on average, and the percentage of ambulatory patients discharged to home increased from 55% to 77%. Limitations This study relied upon the retrospective analysis of data from 6 collectors, and the intervention lacked physical therapy coverage for 7 days per week. Conclusions The improvements in outcomes demonstrated the value and feasibility of a physical therapist–led early mobilization program.


PEDIATRICS ◽  
1990 ◽  
Vol 86 (6) ◽  
pp. 1005-1005
Author(s):  
RICHARD E. NEIBERGER

To the Editor.— In 1975, an Ad Hoc Task Force on Circumcision of the American Academy of Pediatrics reported that "there is no absolute medical indication for routine circumcision of the newborn."1 In 1983, both the American Academy of Pediatrics and the American College of Obstetrics and Gynecology jointly published Guidelines to Perinatal Care in which routine neonatal circumcision was discouraged.2 Since 1983, many public tax-supported hospitals simply stopped performing neonatal circumcision. Circumcision is no longer an option at many major public hospitals.


2017 ◽  
Vol 24 (11) ◽  
pp. 1485-1498 ◽  
Author(s):  
Riley Bove ◽  
Tanuja Chitnis ◽  
Bruce AC Cree ◽  
Mar Tintoré ◽  
Yvonne Naegelin ◽  
...  

Background: There is a pressing need for robust longitudinal cohort studies in the modern treatment era of multiple sclerosis. Objective: Build a multiple sclerosis (MS) cohort repository to capture the variability of disability accumulation, as well as provide the depth of characterization (clinical, radiologic, genetic, biospecimens) required to adequately model and ultimately predict a patient’s course. Methods: Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT) is an international multi-center, prospectively enrolled cohort with over a decade of comprehensive follow-up on more than 1000 patients from two large North American academic MS Centers (Brigham and Women’s Hospital (Comprehensive Longitudinal Investigation of Multiple Sclerosis at the Brigham and Women’s Hospital (CLIMB; BWH)) and University of California, San Francisco (Expression/genomics, Proteomics, Imaging, and Clinical (EPIC))). It is bringing online more than 2500 patients from additional international MS Centers (Basel (Universitätsspital Basel (UHB)), VU University Medical Center MS Center Amsterdam (MSCA), Multiple Sclerosis Center of Catalonia-Vall d’Hebron Hospital (Barcelona clinically isolated syndrome (CIS) cohort), and American University of Beirut Medical Center (AUBMC-Multiple Sclerosis Interdisciplinary Research (AMIR)). Results and conclusion: We provide evidence for harmonization of two of the initial cohorts in terms of the characterization of demographics, disease, and treatment-related variables; demonstrate several proof-of-principle analyses examining genetic and radiologic predictors of disease progression; and discuss the steps involved in expanding SUMMIT into a repository accessible to the broader scientific community.


2014 ◽  
Vol 18 (12) ◽  
pp. 74-84

Singapore's Khoo Teck Puat Hospital achieves HIMSS Analytics Stage 6. PSR-Agility wins second consecutive ROAR Award for “Best Orphan Drug CRO”. Ooredoo Myanmar maternity app “maymay” wins bronze at 2014 Stevie Awards for Women in Business. Vietnam and IRRI jointly craft strategy to boost country's rice industry. Cognizant completes acquisition of TriZetto, creating a fully-integrated healthcare technology and operations leader. Teduglutide granted orphan drug designation in Japan. Murata joins Singapore's EcoCampus initiative. AbbVie acquires manufacturing facility in Singapore; further expands capabilities in Asia. Regen BioPharma acquires University of Toronto cancer stem cell intellectual property. Vetter opens office to support growing Asian healthcare market. Ceapro's research scientist, Bernhard Seifried, Ph.D., honored with Scientific Achievement & Innovation Award from BioAlberta. U.S. Department of Agriculture awards telemedicine grant to Good Samaritan Hospital. UCB and Daiichi Sankyo partner to bring treatment to people living with epilepsy in Japan. Amgen opens Next-Generation Biomanufacturing Facility in Singapore. Women dominate Rice Scientist awards.


2018 ◽  
Vol 17 (2) ◽  
pp. 55-62 ◽  
Author(s):  
Nimaljeet Tarango ◽  
Andrea Gergay Baird

Pulmonary arterial hypertension (PAH) is a serious, chronic, progressive cardiopulmonary disease. PAH is associated with several concomitant conditions, as well as drugs and toxins.12 Methamphetamine abuse is likely associated with the development of PAH.3 Methamphetamine abuse is epidemic in the United States and abroad, with rates of new users escalating since 2012. There are over 100,000 new users annually as young as 12 years old. Treating a patient with a history of methamphetamine abuse poses many challenges for a clinician, including nonadherence, therapeutic treatment selection, complex psychosocial issues, and relapse or continued drug abuse. Patients with methamphetamine-associated PAH (Meth-APAH) have higher mortality rates when compared to idiopathic PAH.3 Having a better understanding of the complexities of addiction and working with a multidisciplinary team that includes a social worker to provide care and counseling to these patients can improve their trajectory. In this article, we will offer insight and background into methamphetamine abuse and addiction, as well as discuss a practical approach for clinicians in treating a patient with Meth-APAH, based on the literature, as well as our personal experiences at University of California, San Francisco Medical Center.


Sign in / Sign up

Export Citation Format

Share Document